Quality of life indicators and S100 neuromarker relationship in patients with type 2 diabetes mellitus with chronic renal failure on program hemodialysis

Yulduz Makhkamovna Urmanova, Alisher Kholikov

Shoshilinch tibbiyot axborotnomasi · 2021-yil

Annotatsiya

Aim. To assess the quality of life of patients with type 2 diabetes before treatment with hemodialysis using the WHO Brief Questionnaire for the Assessment of Quality of Life (WHOQOL-BREF) and the Hamilton Depression Scale, taking into account the degree of neuromarker S100.Material and methods. We examined and examined in total for the period from January 1, 2019 to January 1, 2021 - 90 patients suffering from type 2 diabetes mellitus with chronic renal failure on programmed hemodialysis.Results. In this article, the authors analyze 90 cases of grade 5 diabetic nephropathy who were on programmed hemodialysis. 43 of them women and 47 men. The obtained results also confirm the literature data that patients with type 2 diabetes mellitus have low quality of life indicators before programmed hemodialysis.Conclusions. The obtained results also confirm the literature data on the need to assess the quality of life of patients with type 2 diabetes against the background of complex therapy and the duration of the hemodialysis treatment.

Maqola ma’lumotlari
MualliflarYulduz Makhkamovna Urmanova, Alisher Kholikov
JurnalShoshilinch tibbiyot axborotnomasi
NashriyotЎзбекистон шошилинч тиббий ёрдам врачлари, ассоциацияси
ISSN2010-9881
Nashr sanasi2021-09-20
Jild14
Son3
TilIngliz
Ilmiy sohaTibbiyot
DOI10.54185/tbem/vol14_iss3/a9
Indeksga qo‘shilgan2026-09-02

DOI: 10.54185/tbem/vol14_iss3/a9 · Maqolaning asl sahifasi · PDF

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAYulduz Makhkamovna Urmanova, & Alisher Kholikov (2021). QUALITY OF LIFE INDICATORS AND S100 NEUROMARKER RELATIONSHIP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CHRONIC RENAL FAILURE ON PROGRAM HEMODIALYSIS. Shoshilinch tibbiyot axborotnomasi, 14(3). https://doi.org/10.54185/tbem/vol14_iss3/a9
GOST (OAK)Yulduz Makhkamovna Urmanova, Alisher Kholikov QUALITY OF LIFE INDICATORS AND S100 NEUROMARKER RELATIONSHIP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CHRONIC RENAL FAILURE ON PROGRAM HEMODIALYSIS // Shoshilinch tibbiyot axborotnomasi. – 2021. – T. 14, № 3. – DOI: 10.54185/tbem/vol14_iss3/a9.
MLAYulduz Makhkamovna Urmanova, and Alisher Kholikov. “QUALITY OF LIFE INDICATORS AND S100 NEUROMARKER RELATIONSHIP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CHRONIC RENAL FAILURE ON PROGRAM HEMODIALYSIS.” Shoshilinch tibbiyot axborotnomasi, 14(3), 2021. https://doi.org/10.54185/tbem/vol14_iss3/a9
ChicagoYulduz Makhkamovna Urmanova, and Alisher Kholikov. “QUALITY OF LIFE INDICATORS AND S100 NEUROMARKER RELATIONSHIP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CHRONIC RENAL FAILURE ON PROGRAM HEMODIALYSIS.” Shoshilinch tibbiyot axborotnomasi, 14(3) (2021). https://doi.org/10.54185/tbem/vol14_iss3/a9
HarvardYulduz Makhkamovna Urmanova, and Alisher Kholikov (2021) ‘QUALITY OF LIFE INDICATORS AND S100 NEUROMARKER RELATIONSHIP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CHRONIC RENAL FAILURE ON PROGRAM HEMODIALYSIS’, Shoshilinch tibbiyot axborotnomasi, 14(3). https://doi.org/10.54185/tbem/vol14_iss3/a9
BibTeX
@article{yulduzmakhkamovnaurmanova2021,
  title = {QUALITY OF LIFE INDICATORS AND S100 NEUROMARKER RELATIONSHIP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH CHRONIC RENAL FAILURE ON PROGRAM HEMODIALYSIS},
  author = {Yulduz Makhkamovna Urmanova and Alisher Kholikov},
  journal = {Shoshilinch tibbiyot axborotnomasi},
  year = {2021},
  volume = {14},
  number = {3},
  doi = {10.54185/tbem/vol14_iss3/a9},
  url = {https://doi.org/10.54185/tbem/vol14_iss3/a9}
}

Boshqa maqola uchun iqtibos tayyorlash

Shoshilinch tibbiyot axborotnomasi jurnalidan boshqa maqolalar

Shoshilinch tibbiyot axborotnomasi — barcha maqolalar · 2021-yil arxivi

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari